ROANOKE, Va.--(BUSINESS WIRE)--June 28, 2006--The Carilion Biomedical Institute (CBI) is pleased to announce that it has partnered to form Roanoke Clinical Research, Inc. (RCR), a new Phase I clinical research clinic that will provide clinical research services to the pharmaceutical and biotech industries. “CBI is thrilled to partner in the start-up of a new company that will supply needed Phase I clinical research services to an industry that faces aggressive drug development timelines and is currently facing capacity shortages for Phase I trials. We have a very experienced team on board and I can’t think of a better place than Roanoke to run this type of operation. RCR will further strengthen the growing biomedical bedrock that has been created in this region,” states Daniel Barchi, President and Chief Executive, Carilion Biomedical Institute.
